相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Teresa C. Horan et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia
Kristine Mace Erlandson et al.
CLINICAL INFECTIOUS DISEASES (2008)
New antimicrobial agents for the treatment of Gram-positive bacterial infections
D. Y. Aksoy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Optimizing therapy for vancomycin-resistant enterococci (VRE)
Peter K. Linden
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients
Debra D. Poutsiaka et al.
JOURNAL OF INFECTION (2007)
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program
Lalitagauri M. Deshpande et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
Helio S. Sader et al.
BMC INFECTIOUS DISEASES (2007)
Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
Mark Benvenuto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: A retrospective case series of 31 patients
JA Segreti et al.
PHARMACOTHERAPY (2006)
Tigecycline: A new glycylcycline for treatment of serious infections
GA Noskin
CLINICAL INFECTIOUS DISEASES (2005)
Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents
HS Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Daptomycin dose-effect relationship against resistant gram-positive organisms
R Cha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program
MC Birmingham et al.
CLINICAL INFECTIOUS DISEASES (2003)
Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center
TP Lodise et al.
CLINICAL INFECTIOUS DISEASES (2002)
Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin
PK Linden et al.
CLINICAL INFECTIOUS DISEASES (2001)
Vancomycin-resistant enterococci
Y Cetinkaya et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
MJ Rybak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia
JM Garbutt et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
